The market immediately responded to these transactions, evident in Orchid Pharma's stock gaining 2% upon opening on the NSE the day after Dhanuka Laboratories' stake sale. Post author By admin Post date November 29, 2023 Dhanuka Labs Sells 2.56% Promoter Stake in Orchid Pharma Orchid Pharma, a Chennai-based pharmaceutical company, witnessed a notable development in its ownership structure… 29 November 2023, • 2 mins read Tags Dhanuka Laboratories, investor, MK Dhanuka, Mutual Fund, NSE, Orchid Pharma, share, share market, Stakeholders, UTI